FdaApplication

BLA 125610

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSpark Therapeutics, Inc.
application_typeBLA
approval_date2017-12-19

Products (1)

ProductActive ingredientStrengthDosage form
LUXTURNA—1.5X10 TO 11 MLInjection

1 product